| Dr Luis A Fiallo, MD, FACP | |
|
1415 Ross Ave, El Centro, CA 92243-4306 | |
| (760) 339-7202 | |
| (760) 339-9904 |
| Full Name | Dr Luis A Fiallo |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 35 Years |
| Location | 1415 Ross Ave, El Centro, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407824600 | NPI | - | NPPES |
| 00C513090 | Medicaid | CA | |
| 1760644686 | Other | CA | INCORPORATED NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | C51309 (California) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | C51309 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Mayo Newhall Hospital | Valencia, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Knd Development 59 Llc | 3678602802 | 144 |
| Scct Medical Group Pc | 4183978026 | 13 |
News Archive
Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. To date, there have been 2,043 human cases including 676 fatalities, mainly occurring in ten Brazilian states including Rio de Janeiro and São Paulo.
A vaccine against the virus that causes cervical cancer and genital warts could reduce persistent infection and disease by 90%, suggest the results of a randomised trial published online by The Lancet Oncology.
Stem cell and regenerative medicine research is an important area of clinical research which promises to change the face of medicine as it will be practiced in the years to come.
Dr. Reddy's Laboratories announced today that it has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex® Reditabs® (desloratadine) in the US market on January 24, 2013.
› Verified 4 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780870899 PECOS PAC ID: 6406760131 Enrollment ID: O20031117000940 |
News Archive
Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. To date, there have been 2,043 human cases including 676 fatalities, mainly occurring in ten Brazilian states including Rio de Janeiro and São Paulo.
A vaccine against the virus that causes cervical cancer and genital warts could reduce persistent infection and disease by 90%, suggest the results of a randomised trial published online by The Lancet Oncology.
Stem cell and regenerative medicine research is an important area of clinical research which promises to change the face of medicine as it will be practiced in the years to come.
Dr. Reddy's Laboratories announced today that it has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex® Reditabs® (desloratadine) in the US market on January 24, 2013.
› Verified 4 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386762300 PECOS PAC ID: 3577476761 Enrollment ID: O20040430001307 |
News Archive
Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. To date, there have been 2,043 human cases including 676 fatalities, mainly occurring in ten Brazilian states including Rio de Janeiro and São Paulo.
A vaccine against the virus that causes cervical cancer and genital warts could reduce persistent infection and disease by 90%, suggest the results of a randomised trial published online by The Lancet Oncology.
Stem cell and regenerative medicine research is an important area of clinical research which promises to change the face of medicine as it will be practiced in the years to come.
Dr. Reddy's Laboratories announced today that it has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex® Reditabs® (desloratadine) in the US market on January 24, 2013.
› Verified 4 days ago
| Entity Name | Emergency And Acute Care Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437103942 PECOS PAC ID: 9537108279 Enrollment ID: O20050502000734 |
News Archive
Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. To date, there have been 2,043 human cases including 676 fatalities, mainly occurring in ten Brazilian states including Rio de Janeiro and São Paulo.
A vaccine against the virus that causes cervical cancer and genital warts could reduce persistent infection and disease by 90%, suggest the results of a randomised trial published online by The Lancet Oncology.
Stem cell and regenerative medicine research is an important area of clinical research which promises to change the face of medicine as it will be practiced in the years to come.
Dr. Reddy's Laboratories announced today that it has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex® Reditabs® (desloratadine) in the US market on January 24, 2013.
› Verified 4 days ago
| Entity Name | Emergency Associates Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003866120 PECOS PAC ID: 8022196518 Enrollment ID: O20080424000144 |
News Archive
Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. To date, there have been 2,043 human cases including 676 fatalities, mainly occurring in ten Brazilian states including Rio de Janeiro and São Paulo.
A vaccine against the virus that causes cervical cancer and genital warts could reduce persistent infection and disease by 90%, suggest the results of a randomised trial published online by The Lancet Oncology.
Stem cell and regenerative medicine research is an important area of clinical research which promises to change the face of medicine as it will be practiced in the years to come.
Dr. Reddy's Laboratories announced today that it has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex® Reditabs® (desloratadine) in the US market on January 24, 2013.
› Verified 4 days ago
| Entity Name | Valencia Pulmonary Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932100070 PECOS PAC ID: 9537221262 Enrollment ID: O20081215000332 |
News Archive
Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. To date, there have been 2,043 human cases including 676 fatalities, mainly occurring in ten Brazilian states including Rio de Janeiro and São Paulo.
A vaccine against the virus that causes cervical cancer and genital warts could reduce persistent infection and disease by 90%, suggest the results of a randomised trial published online by The Lancet Oncology.
Stem cell and regenerative medicine research is an important area of clinical research which promises to change the face of medicine as it will be practiced in the years to come.
Dr. Reddy's Laboratories announced today that it has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex® Reditabs® (desloratadine) in the US market on January 24, 2013.
› Verified 4 days ago
| Entity Name | Knd Development 59 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740519081 PECOS PAC ID: 3678602802 Enrollment ID: O20100724000249 |
News Archive
Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. To date, there have been 2,043 human cases including 676 fatalities, mainly occurring in ten Brazilian states including Rio de Janeiro and São Paulo.
A vaccine against the virus that causes cervical cancer and genital warts could reduce persistent infection and disease by 90%, suggest the results of a randomised trial published online by The Lancet Oncology.
Stem cell and regenerative medicine research is an important area of clinical research which promises to change the face of medicine as it will be practiced in the years to come.
Dr. Reddy's Laboratories announced today that it has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex® Reditabs® (desloratadine) in the US market on January 24, 2013.
› Verified 4 days ago
| Entity Name | Scct Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952878795 PECOS PAC ID: 4183978026 Enrollment ID: O20181113002226 |
News Archive
Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. To date, there have been 2,043 human cases including 676 fatalities, mainly occurring in ten Brazilian states including Rio de Janeiro and São Paulo.
A vaccine against the virus that causes cervical cancer and genital warts could reduce persistent infection and disease by 90%, suggest the results of a randomised trial published online by The Lancet Oncology.
Stem cell and regenerative medicine research is an important area of clinical research which promises to change the face of medicine as it will be practiced in the years to come.
Dr. Reddy's Laboratories announced today that it has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex® Reditabs® (desloratadine) in the US market on January 24, 2013.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Luis A Fiallo, MD, FACP 23845 Mcbean Pkwy, Valencia, CA 91355-2001 Ph: (661) 200-1122 | Dr Luis A Fiallo, MD, FACP 1415 Ross Ave, El Centro, CA 92243-4306 Ph: (760) 339-7202 |
News Archive
Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. To date, there have been 2,043 human cases including 676 fatalities, mainly occurring in ten Brazilian states including Rio de Janeiro and São Paulo.
A vaccine against the virus that causes cervical cancer and genital warts could reduce persistent infection and disease by 90%, suggest the results of a randomised trial published online by The Lancet Oncology.
Stem cell and regenerative medicine research is an important area of clinical research which promises to change the face of medicine as it will be practiced in the years to come.
Dr. Reddy's Laboratories announced today that it has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex® Reditabs® (desloratadine) in the US market on January 24, 2013.
› Verified 4 days ago
Mr. Alidad M. Zadeh, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 S. Imperial Ave, Ste #3, El Centro, CA 92243 Phone: 760-339-2802 Fax: 760-355-9520 | |
Dr. Syed Hasnat Ahmed, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1271 Ross Ave, El Centro, CA 92243 Phone: 760-335-3030 Fax: 760-335-3035 | |
Sohaib Tariq, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 790 W Orange Ave Ste B, El Centro, CA 92243 Phone: 760-353-3222 Fax: 760-353-5607 | |
Shahid Hussain, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2205 Ross Ave, Ste 101, El Centro, CA 92243 Phone: 760-353-0404 Fax: 760-353-0392 | |
Ramin Seyed Berenji, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2205 Ross Ave, Ste 101, El Centro, CA 92243 Phone: 760-353-0404 Fax: 760-353-0392 | |
Dr. Prabhdeep Singh, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2061 Ross Ave, Suite B, El Centro, CA 92243 Phone: 760-352-5800 Fax: 760-545-0249 | |
Roberto Navarro, M.D., Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1415 Ross Ave, El Centro, CA 92243 Phone: 760-482-5075 |